ArticleACS medicinal chemistry letters2021

Improved Synthesis of New FDA-Approved Treatment for KRAS G12C Mutation in Non-small Cell Lung Cancer.

Robert B KargboPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.